Open Actively Recruiting

A NOVEL MULTIPLEX IMMUNOASSAY FOR PREDICTING INTRAVESICAL BCG RESPONSE IN PATIENTS WITH INTERMEDIATE OR HIGH-RISK NON-MUSCLE INVASIVE BLADDER CANCER

About

Brief Summary

This study has not yet been registered on ClinicalTrials.gov, which is currently a pre-requisite for display of detailed eligibility criteria.

Phase
N/A

Eligibility

Minimum Age
N/A
Maximum Age
N/A

Join this Trial

Contact our clinical trial navigators for opportunities that may be suitable for you
Share:
Study Stats
Protocol No.
21-001975
Category
Bladder Cancer
Contact
Gregory Ellis